Our global pharmaceutical client needed to prioritize launch regions for a biosimilar in a large
Disease Area Strategy: Business Development (BD) Assessment
Prescient developed a BD assessment framework to identify attractive candidates in an oncology indication with a high unmet need.
Value Proposition Development: Differentiating a New Entrant in a Market with Well-Entrenched Competition
Our client, a global pharmaceutical company, had a drug in development for a disease area
Prescient assessed opportunities across patient segments to guide our client’s go-to-market strategies.